You are here:Home/Michelson Medical Research Foundation
Medical Research | Michelson Medical Research Foundation (MMRF)
The Michelson Medical Research Foundation [MMRF] was founded in 1995 by Gary Karlin Michelson, M.D., with the aim of developing groundbreaking new medical technologies and improving upon existing treatments through investments in ethical, forward thinking medical research and education.
We create opportunities for innovative, cross-disciplinary medical research, education and entrepreneurial resources through respective partnerships with the USC Michelson Center for Convergent Bioscience located at the University of Southern California, UW's Institute for Protein Design, the Physicians Committee for Responsible Medicine and Wharton School's Startup Challenge.
We form alliances with institutions advancing innovative research, such as the Human Vaccines Project, and promote the development of disruptive technologies in immunology to combat against current and future global diseases.
Since its inception in 1995, the Michelson Medical Research Foundation has been committed to providing support for forward thinking endeavors in medical science. At the heart of the Michelson Medical Research Foundation is its founder: Dr. Gary K. Michelson, a board-certified Orthopedic Spinal Surgeon with more than 25 years of practical experience, 110 research papers / publications to his credit and no less than 950 issued or internationally pending patents that have heavily contributed to the field of spinal surgery.
The Michelson Medical Research Foundation’s ambitious goals are evident in its ever-expanding portfolio of projects and initiatives:
Proteins solve the challenges faced during evolution, but the proteins which exist today took billions of years to evolve to this state. The goal of Protein Design is to create new “synthetic” proteins which can help solve the problems we face now in modern times.
Since 2014, the Michelson Medical Research Foundation has entered the realm of Bioscience. By donating $50 million dollars to the University of Southern California, MMRF has made possible the USC Michelson Center for Convergent Bioscience and its interim campus, The Bridge@USC. Inaugurated on November 1st, 2017, the venue is uniting experts across disciplines to generate more innovative and collaborative research.
Michelson Medical Research Foundation has a longstanding history of encouraging technological, and business innovation in the nation’s elite universities. MMRF is a former sponsor of the MIT $100k Entrepreneurship Competition, the Business Association of Stanford Entrepreneurial Students and, since 2009, is a platinum sponsor of the Wharton Startup Challenge. With over $350K in prizes distributed to aspiring entrepreneurs, MMRF has fostered collaboration between student entrepreneurs and seasoned mentors at both graduate and post-graduate levels.
The Michelson Ethical Research & Education Initiative, a partnership between the Michelson Medical Research Foundation and the Physicians Committee for Responsible Medicine is aimed at making medical research and education more ethical, more effective. Innovations in these fields are far superior to animal experiments and will end the exploitation and suffering of animals for these purposes.
The Michelson Medical Research Foundation [MMRF] has funded a $20 million initiative with the Human Vaccines Project to support young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.